SCHEPIS, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.165
AS - Asia 5.092
EU - Europa 4.617
SA - Sud America 945
AF - Africa 110
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 13
Totale 21.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.036
CN - Cina 1.786
GB - Regno Unito 1.592
SG - Singapore 1.532
IT - Italia 975
BR - Brasile 761
HK - Hong Kong 647
SE - Svezia 478
DE - Germania 449
VN - Vietnam 368
RU - Federazione Russa 297
UA - Ucraina 175
KR - Corea 166
TR - Turchia 155
FI - Finlandia 129
ID - Indonesia 125
FR - Francia 110
BG - Bulgaria 89
AR - Argentina 76
IN - India 64
MX - Messico 55
NL - Olanda 55
CA - Canada 54
BD - Bangladesh 41
ES - Italia 40
JP - Giappone 38
ZA - Sudafrica 34
AT - Austria 32
LT - Lituania 31
PL - Polonia 31
EC - Ecuador 28
BE - Belgio 27
CO - Colombia 23
AU - Australia 21
MA - Marocco 21
EG - Egitto 19
RO - Romania 19
IQ - Iraq 16
CL - Cile 15
MY - Malesia 15
PK - Pakistan 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
KE - Kenya 12
PY - Paraguay 12
PE - Perù 11
UZ - Uzbekistan 11
IE - Irlanda 10
CH - Svizzera 9
IL - Israele 9
PH - Filippine 8
SA - Arabia Saudita 8
VE - Venezuela 8
AL - Albania 7
AZ - Azerbaigian 7
EU - Europa 6
GE - Georgia 6
KZ - Kazakistan 6
LV - Lettonia 6
SC - Seychelles 6
TH - Thailandia 6
TN - Tunisia 6
BO - Bolivia 5
GR - Grecia 5
HU - Ungheria 5
IR - Iran 5
KG - Kirghizistan 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BH - Bahrain 4
BY - Bielorussia 4
BZ - Belize 4
EE - Estonia 4
HR - Croazia 4
JM - Giamaica 4
SI - Slovenia 4
DZ - Algeria 3
HN - Honduras 3
JO - Giordania 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
QA - Qatar 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KH - Cambogia 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
Totale 21.943
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.347
Fairfield 1.227
Ashburn 1.048
Southend 972
Singapore 944
Woodbridge 726
Hefei 722
Hong Kong 631
Chandler 600
Houston 571
Seattle 490
London 420
Cambridge 415
Wilmington 414
Ann Arbor 327
Modena 322
Nyköping 322
Jacksonville 309
Dearborn 255
Dallas 224
Beijing 218
New York 180
Los Angeles 166
Seoul 157
Chicago 137
Ho Chi Minh City 122
San Diego 119
The Dalles 99
Princeton 96
Hanoi 94
Jakarta 93
Sofia 88
Moscow 80
Izmir 72
Shanghai 71
Bologna 66
Helsinki 63
Munich 63
São Paulo 61
Eugene 56
Buffalo 55
Council Bluffs 55
Redwood City 50
Milan 47
Salt Lake City 46
Grafing 39
Kent 39
Yalova 39
Nuremberg 35
Nanjing 34
Frankfurt am Main 33
Tokyo 33
Des Moines 32
Rio de Janeiro 31
Elk Grove Village 30
Redondo Beach 30
Brooklyn 28
Brussels 27
Guangzhou 27
Jersey City 27
Bremen 26
Columbus 25
Boardman 24
Tampa 24
Turku 24
Falls Church 22
Lauterbourg 22
Boston 20
Orem 20
Portsmouth 20
Brasília 19
Mexico City 19
Warsaw 19
Stockholm 18
Johannesburg 17
Montreal 17
Phoenix 17
Rome 17
Toronto 16
Wuhan 16
Atlanta 15
Changsha 15
Da Nang 15
Denver 15
Jinan 15
Parma 15
Vienna 15
Belo Horizonte 14
Mumbai 14
Düsseldorf 13
Melbourne 13
Paris 13
San Jose 13
Sterling 13
Amsterdam 12
Manchester 12
Norwalk 12
Bari 11
Buenos Aires 11
Curitiba 11
Totale 15.793
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 658
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 394
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 391
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 382
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 335
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 332
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 320
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 313
A new device for ultrasound-guided peripheral venous access 308
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 307
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis 282
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 271
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 266
Consensus conference on TIPS management: Techniques, indications, contraindications 265
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 265
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 264
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. 261
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 259
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 254
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 254
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 253
JLB: a flexible and effective device in critical patients. Review of clinical cases 251
30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice 250
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 249
Obese zebrafish: A small fish for a major human health condition 246
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells. 239
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 238
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 232
Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. 229
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 224
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 224
A RANDOMIZED TRIAL OF THE SAFETY AND HEPATIC HEMODYNAMIC EFFECTS OF INTRAVENOUS CONIVAPTAN IN EUVOLEMIC OR HYPERVOLEMIC CIRRHOTIC PATIENTS 218
Chemoprevention of hepatocellular carcinoma 217
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials 216
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 213
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 211
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS 211
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 210
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis” 210
Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. 207
Protection of human endothelial cells from oxidative stress: Role of Ras-ERK1/2 signaling 203
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 202
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen? 202
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 201
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. 199
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? 197
Paradoxical embolization in TIPS: take a closer look to the heart 195
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives 194
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. 193
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 191
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 189
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 188
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. 183
The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45β2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway 182
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 181
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis 177
When and how to treat acute hepatitis C? 173
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 171
Natural history of chronic HBV in northern Italy: Morbidity and morality after 30 years 170
Transjugular intrahepatic portosystemic shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: a real-life, case-control study 169
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 165
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 165
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions 161
Pathophysiology of portal hypertension and variceal bleeding 161
Baveno VII – Renewing consensus in portal hypertension 161
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 154
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 148
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 147
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 147
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure 147
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 146
Akt1/Akt2 inhibition and development of hepatocellular carcinoma 146
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease 144
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 143
Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis 142
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 141
Transient elastography and ultrasonography: Optimal evaluation of liver fibrosis and cirrhosis in patients with chronic hepatitis B concurrent with nonalcoholic fatty liver disease 140
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis 137
Monitoring Treatment of Cirrhosis and Portal Hypertension 137
Meta-analysis of Transarterial Embolization in Patients with Unresectable Hepatocellular Carcinoma: Dr Camma and colleagues respond 137
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 134
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease 132
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 130
Reply to: “It takes two “eyes” to see in depth” 130
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) 130
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis 129
Baveno IV Consensus Statements: Predictive Models in Portal Hypertension 128
Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis 127
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 126
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 125
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment 122
The OMICs window into nonalcoholic fatty liver disease (NAFLD) 118
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 114
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 111
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites” 109
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974, (S0168827821022996), (10.1016/j.jhep.2021.12.022)] 108
Physical activity in liver transplant recipients: a large multicenter study 108
Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis 108
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 106
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation 106
Totale 20.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.260
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.387 0 0 0 0 0 221 157 288 109 325 183 104
2021/20221.883 132 156 157 66 76 111 132 158 213 148 321 213
2022/20231.751 216 209 140 164 156 261 21 179 183 29 129 64
2023/20241.173 51 63 79 120 185 91 154 114 66 21 91 138
2024/20255.343 139 66 67 343 1.000 755 347 393 774 310 548 601
2025/20265.147 777 581 1.087 1.219 1.273 210 0 0 0 0 0 0
Totale 22.217